Familial exudative vitreoretinopathy and osteoporosis-pseudoglioma syndrome caused by a mutation in the LRP5 gene [3]

Archives of Ophthalmology

Volumn 125, Issue 3, 2007, Pages 431-432

  Drenser, Kimberly A ^a   Trese, Michael T ^b  

^a ASSOCIATED RETINAL CONSULTANTS   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5;

CLINICAL FEATURE; FAMILIAL DISEASE; FAMILIAL EXUDATIVE VITREORETINOPATHY; GENE MUTATION; HUMAN; LETTER; NORRIE DISEASE; OSTEOPOROSIS; OSTEOPOROSIS PSEUDOGLIOMA SYNDROME; PRIORITY JOURNAL; RETINA FOLD; VITREORETINOPATHY;

EID: 33947240731     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.125.3.431-c     Document Type: Letter

References (3)

1. Lai TY, Wong VW, Lam DS. Asymmetrical ocular involvement and persistent fetal vasculature in an adult with osteoporosis-pseudoglioma syndrome. Arch Ophthalmol. 2006;124:422-423.
2. Drenser KA, Dailey W, Capone A, Trese MT. Genetic evaluation to establish the diagnosis of X-linked familial exudative vitreoretinopathy. Ophthalmic Genet. 2006;27:75-78.
3. Pendergast SD, Trese MT. Familial exudative vitreoretinopathy: results of surgical management. Ophthalmology. 1998;105:1015-1023.